Back to top
more

HealthEquity (HQY)

(Real Time Quote from BATS)

$90.77 USD

90.77
229,194

-0.18 (-0.20%)

Updated Aug 7, 2025 01:56 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (98 out of 246)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Is HealthEquity (HQY) a Great Growth Stock?

by Zacks Equity Research

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider HealthEquity (HQY).

Zacks Equity Research

Teladoc (TDOC) Up 22% in a Year: Will the Rally Continue?

by Zacks Equity Research

Teladoc's increasing visits and subscriptions are likely to aid revenue growth. This will further drive its share price.

Zacks Equity Research

Zacks.com featured highlights include: Comcast, Enterprise Products, HealthEquity and Pioneer Natural

by Zacks Equity Research

Zacks.com featured highlights include: Comcast, Enterprise Products, HealthEquity and Pioneer Natural

Tirthankar Chakraborty headshot

4 of the Best Stocks to Buy for Superb Earnings Growth

by Tirthankar Chakraborty

We select four stocks that have striking earnings growth and positive estimate revisions.

Tirthankar Chakraborty headshot

New Strong Buy Stocks for June 7th

by Tirthankar Chakraborty

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday

Zacks Equity Research

HealthEquity (HQY) Earnings & Revenues Top Estimates in Q1

by Zacks Equity Research

Higher revenues, solid segmental performance and expansion in margins benefit HealthEquity's (HQY) Q1 earnings.

Zacks Equity Research

HealthEquity (HQY) Tops Q1 Earnings and Revenue Estimates

by Zacks Equity Research

HealthEquity (HQY) delivered earnings and revenue surprises of 20.59% and 3.65%, respectively, for the quarter ended April 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

ICLR or HQY: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ICLR vs. HQY: Which Stock Is the Better Value Option?

Zacks Equity Research

HealthEquity (HQY) Down 16.1% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

PRAH vs. HQY: Which Stock Is the Better Value Option?

by Zacks Equity Research

PRAH vs. HQY: Which Stock Is the Better Value Option?

Zacks Equity Research

HealthEquity (HQY) Earnings & Revenues Beat Estimates in Q4

by Zacks Equity Research

HealthEquity (HQY) witnesses strong HSA member growth in the fourth quarter of fiscal 2019.

Zacks Equity Research

PRAH vs. HQY: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

PRAH vs. HQY: Which Stock Is the Better Value Option?

Zacks Equity Research

HealthEquity (HQY) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

HealthEquity (HQY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

HealthEquity (HQY) Surges: Stock Moves 8.6% Higher

by Zacks Equity Research

HealthEquity (HQY) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

Zacks Equity Research

HealthEquity's (HQY) Preliminary Q4 Results Cheer Investors

by Zacks Equity Research

HealthEquity's (HQY) solid guidance for fiscal 2019 favors stock.

Zacks Equity Research

HealthEquity (HQY) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

HealthEquity (HQY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Will HealthEquity, Inc. (HQY) Continue to Surge Higher?

by Zacks Equity Research

As of late, it has definitely been a great time to be an investor in HealthEquity, Inc.

Zacks Equity Research

Is HealthEquity (HQY) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Is (HQY) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Teladoc Expands Services with Virtual Back Pain Treatment

by Zacks Equity Research

Teladoc's (TDOC) new addition of virtual back pain treatment will broaden its suite of products and services.

Zacks Equity Research

Here is Why Growth Investors Should Buy HealthEquity (HQY) Now

by Zacks Equity Research

HealthEquity (HQY) could produce exceptional returns because of its solid growth attributes.

Sreyoshi Mukherjee headshot

3 Medical Services Stocks to Buy in 2019: HQY, AMEH & OPGN

by Sreyoshi Mukherjee

Here we discuss three profitable Medical Services stocks as the industry booms.

Zacks Equity Research

Why Is HealthEquity (HQY) Down 29.3% Since Last Earnings Report?

by Zacks Equity Research

HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Is HealthEquity (HQY) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (HQY) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

MEDP or HQY: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

MEDP vs. HQY: Which Stock Is the Better Value Option?

Zacks Equity Research

Here's Why You Should Hold HealthEquity (HQY) Stock for Now

by Zacks Equity Research

HealthEquity's (HQY) fiscal third-quarter results hold promise while competition is stiff.